Every recall we track for ENDO USA, Inc. — 11 in all — plus the complaints and injury reports the public filed about them.
Endo USA recalls 5x1mL Buprenorphine injections due to crystallization risk. Affected lots expire 02/2027 and 03/2027. Contact for return instructions.
Endo recalls 5mg Everolimus tablets due to impurity IP-C failing quality specs. Rx-only medication with specific lot numbers and expiration dates. Consumers should contact pharmacy for guidance.
Endo recalls 10mg Everolimus tablets with impurity IP-C out of specification. Rx-only medication; affected lots manufactured in Chestnut Ridge, NY. Stop using if you have these specific lots.
Endo recalls 2.5mg Everolimus tablets with impurity IP-C out of specification. Rx-only medication may pose safety risks. Check your carton for lot numbers and expiration dates.
Endo recalls Everolimus 7.5mg tablets due to impurity IP-C failing specifications. Rx-only medication with specific lot numbers and expiration dates. Consumers should contact Endo for details.
Endo recalls Everolimus 5mg tablets due to impurity IP-C failing specifications. Rx-only product with specific lot number. Contact for return instructions.
ENDO USA recalls Adrenalin Chloride Solution (Epine: 30mg/30mL vials) due to misleading label similar to FDA-approved epinephrine injection. Consumers should check product details and contact for guidance.
Endo recalls Clonazepam orally disintegrating tablets with incorrect labeling. Some cartons were mislabeled but blister strips show correct strength. No action needed as product is safe to use.
Endo USA recalls 2mg Clonazepam orally disintegrating tablets with incorrect labeling. Some cartons show wrong strength but blister strips are correct. No action needed as the tablets are safe to use.
Endo USA recalls 0.125 mg Clonazepam orally disintegrating tablets with incorrect labeling. Some cartons show wrong strength but blister strips indicate correct dosage. No action needed as the error is not dangerous.
